A distinctive botanical
Saffron is one of the featured active ingredients in Minnexa® Daily Mood Support. Each capsule contains 30 mg of saffron, identified on the label as Crocus sativus L., stigma. The botanical name and plant part are important details. They tell readers which ingredient is declared, rather than leaving “saffron” as an unexplained marketing phrase. Our formula also contains magnesium as magnesium glycinate, L-theanine and Anandamide Oil Complex. This guide focuses on the saffron entry while keeping the complete formula in view.
Understanding the plant part
The stigma is the flower part identified in the Supplement Facts panel. Botanical identity matters when reading a supplement label because a plant name alone does not describe every possible preparation. Whole botanical material, extracts and standardized extracts are not interchangeable descriptions. Minnexa’s current label declares saffron stigma; it does not declare a branded extract or a standardized concentration of individual constituents. We therefore do not describe it as a particular patented extract or assign a crocin or safranal percentage that has not been documented.
What researchers have explored
A published randomized trial in healthy adults examined a standardized saffron extract over eight weeks, including measures of mood and response to a laboratory stressor. The study used a specific research material and protocol. It is useful as an example of how saffron is investigated, but its findings should be read in that context. Study size, participant characteristics, the preparation used and the measured outcomes all influence what a trial can establish. A positive result is not a guarantee for every person or every saffron product.
Why matching milligrams is not enough
That trial used 30 mg of a standardized extract. Minnexa also declares 30 mg of saffron, but matching the numerical amount does not establish that the materials are equivalent. The label does not identify the same extract or its standardization. It would therefore be misleading to say the study clinically proves Minnexa, to promise the same response, or to present a research result as a finished-product outcome. A useful ingredient guide makes the difference visible instead of asking customers to infer an equivalence.
A focused place in the formula
Saffron is included alongside three other active ingredients in a capsule marketed for daily mood support. The label allows customers to examine each amount separately. It does not claim that combining these ingredients multiplies a study’s effects, makes an ingredient work faster or guarantees relaxation. Describing the botanical clearly is more informative than using unexplained superlatives. We highlight saffron because it is a specific part of our formula, while recognizing that the full product would need its own evidence for specific clinical performance claims.
Choosing and using capsules
Each bottle contains 30 capsules. The serving size is one capsule, and the adult direction is one capsule daily. Taking additional capsules to recreate a different research protocol is not recommended by our label. Before using a dietary supplement, discuss your circumstances with a physician, particularly if you take medication or have a medical condition. A supplement should not be used to replace prescribed treatment or to self-treat a mood disorder. Persistent or concerning symptoms deserve qualified medical attention.
Information before purchase
The other active entries are Anandamide Oil Complex 180 mg, L-theanine 100 mg and magnesium 15 mg as magnesium glycinate, providing 4% Daily Value. Other ingredients are Hypromellose (Vegetable Cellulose), Rice Fiber and Plant Derived Enzyme. Keep the product out of reach of children. Read the full label and the companion ingredient guides before purchase. The product card below provides current bottle bundles; subscription choices are available on the product page. This educational article explains the formula and its research context without promising an individual result.
Sources and further reading
Healthy-adult saffron trial, 2021
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.